<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医麦客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-11T11:09:45+08:00</updated>
  <subtitle>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>国内原创基因治疗产品获FDA批准临床，标志着源兴基因病毒载体CDMO服务平台又一成果丨医麦猛爆料</title>
    <updated>2020-12-11T00:47:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/R6esBWOIidztmIyp4Ix1Og</id>
    <link href="https://mp.weixin.qq.com/s/R6esBWOIidztmIyp4Ix1Og" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融资丨沙砾生物宣布完成1亿元A轮融资，推进TIL疗法在多个实体瘤适应症的临床研究</title>
    <updated>2020-12-11T00:47:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/Peku_29PXeBZjD2g_l2rUQ</id>
    <link href="https://mp.weixin.qq.com/s/Peku_29PXeBZjD2g_l2rUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠疫苗上市前夕，安全性成为讨论焦点丨医麦新观察</title>
    <updated>2020-12-11T00:47:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/5zTyRstwWXQ92AC1GPU65w</id>
    <link href="https://mp.weixin.qq.com/s/5zTyRstwWXQ92AC1GPU65w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球首例BCMA CAR-T细胞治疗难治性原发性浆细胞白血病，单细胞转录组测序发现CAR-T细胞增殖和杀伤的特征性过程</title>
    <updated>2020-12-11T00:47:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/0QV5QiL0MiZwSiixXgSitg</id>
    <link href="https://mp.weixin.qq.com/s/0QV5QiL0MiZwSiixXgSitg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最新：重庆精准生物双靶点CAR-T细胞的IND申请获默示许可，治疗复发/难治性多发性骨髓瘤丨医麦猛爆料</title>
    <updated>2020-12-11T00:47:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/N76lbgj1AtwAtifhmQH06A</id>
    <link href="https://mp.weixin.qq.com/s/N76lbgj1AtwAtifhmQH06A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>张明智教授：十年探索 不断创新——NKT细胞淋巴瘤治疗经验分享</title>
    <updated>2020-12-11T00:47:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/XO_J1YU6903YwoNiIwy8BA</id>
    <link href="https://mp.weixin.qq.com/s/XO_J1YU6903YwoNiIwy8BA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「峰客访谈」伯豪生物总经理肖华胜：单细胞测序技术已应用于免疫治疗、细胞治疗的研究中</title>
    <updated>2020-12-11T00:47:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/3To2c-h-H23_L1bas2bhAQ</id>
    <link href="https://mp.weixin.qq.com/s/3To2c-h-H23_L1bas2bhAQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>AAV基因治疗罕见遗传病潜力巨大，临床研究显示疗效积极丨医麦猛爆料</title>
    <updated>2020-12-10T07:41:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/iL31qKzKjEfb8jPaIPiToA</id>
    <link href="https://mp.weixin.qq.com/s/iL31qKzKjEfb8jPaIPiToA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ASH 2020：北恒生物公布通用型CAR-T产品CTA101治疗复发性或难治性B细胞急性淋巴细胞白血病研究数据</title>
    <updated>2020-12-10T07:41:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/n-I0d8gKsMCjFqgF5BDgRA</id>
    <link href="https://mp.weixin.qq.com/s/n-I0d8gKsMCjFqgF5BDgRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球首款！华龛生物3D微载体产品获得CDE药用辅料资质丨医麦猛爆料</title>
    <updated>2020-12-10T07:41:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/sItsuYmY_ybwGlOVt2aEtA</id>
    <link href="https://mp.weixin.qq.com/s/sItsuYmY_ybwGlOVt2aEtA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>又一款ADC药物申报临床！和元生物旗下子公司的DR5 ADC临床申请获得受理丨医麦猛爆料</title>
    <updated>2020-12-10T07:41:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/soCS4uit8J3bYOTRdvXNTw</id>
    <link href="https://mp.weixin.qq.com/s/soCS4uit8J3bYOTRdvXNTw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>随着国家对人类遗传资源的监管力度加大，生物医药企业如何从容应对人类遗传资源监管及最新注册法规丨医麦猛爆料</title>
    <updated>2020-12-10T07:41:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/mAtfJxBxPH1ZT_DjD3Dv3g</id>
    <link href="https://mp.weixin.qq.com/s/mAtfJxBxPH1ZT_DjD3Dv3g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>张会来教授：霍奇金淋巴瘤的未来治疗趋势是传统治疗与靶向治疗的结合</title>
    <updated>2020-12-10T07:41:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/f2EncT_hwIkh8Y7eycZgbw</id>
    <link href="https://mp.weixin.qq.com/s/f2EncT_hwIkh8Y7eycZgbw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「峰客访谈」新格元生物副总裁訾晓渊：单细胞测序，下一代遗传学上的显微镜</title>
    <updated>2020-12-10T07:41:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/H0c8lDfQUFtcn7bVNtaPwg</id>
    <link href="https://mp.weixin.qq.com/s/H0c8lDfQUFtcn7bVNtaPwg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>细胞治疗产业蓬勃发展，需要更加可靠、高效和灵活的生产管理平台丨医麦新观察</title>
    <updated>2020-12-09T09:06:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/Ve-w7hq-oQB8aYe3TD1ZLQ</id>
    <link href="https://mp.weixin.qq.com/s/Ve-w7hq-oQB8aYe3TD1ZLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>邀请函 | 2020年创新药物临床前研究学术研讨会</title>
    <updated>2020-12-09T09:06:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/1Yq5zqQigEfR9EnByo0r6Q</id>
    <link href="https://mp.weixin.qq.com/s/1Yq5zqQigEfR9EnByo0r6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>东曜药业公布ADC在研药物TAA013 I期研究结果丨医麦猛爆料</title>
    <updated>2020-12-09T09:06:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/QvkEPDdd_33iubRmqoITnA</id>
    <link href="https://mp.weixin.qq.com/s/QvkEPDdd_33iubRmqoITnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>复盘ASH2020：聚焦BCMA CAR-T，自体、同种异体、非病毒载体、双靶点齐上阵丨医麦新观察</title>
    <updated>2020-12-09T09:06:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/ha_MKgXUqbwY5GdWA_BAPw</id>
    <link href="https://mp.weixin.qq.com/s/ha_MKgXUqbwY5GdWA_BAPw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最后两天优惠丨人类遗传资源与生物医药注册法规官方解读</title>
    <updated>2020-12-09T09:06:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/M_Yuz1bp_iDmL-YZ2cRwCg</id>
    <link href="https://mp.weixin.qq.com/s/M_Yuz1bp_iDmL-YZ2cRwCg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>高力教授：ASCT治疗T细胞淋巴瘤（新桥）经验分享</title>
    <updated>2020-12-09T09:06:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/XgYY3HVNe9zvrcgSKw5wPg</id>
    <link href="https://mp.weixin.qq.com/s/XgYY3HVNe9zvrcgSKw5wPg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>